TCRRUnknown

TCR2 THERAPEUTICS INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for TCR2 THERAPEUTICS INC. (TCRR), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are TCRR insiders buying or selling?

TCR2 THERAPEUTICS INC. insiders reported 10 open-market buys ($65.7M) and 29 sells ($16.8M) across 39 Form 4 filings — a net buying position of $48.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 31, 2023)

Total Form 4 filings
39
SEC EDGAR
Insider filers
16
Insider buys (10)
$65.7M
Insider sells (29)
$16.8M

Insider sentiment

Net buying

Net insider flow of $48.9M in net buying.

Recent TCRR insider transactions

DateInsiderRoleTypeSharesPriceValue
May 31, 2023Kevin C Tang10% OwnerPurchase50.0K$1.72$86.0K
May 24, 2023MPM ASSET MANAGEMENT LLC10% OwnerSale70.2K$1.88$131.9K
May 24, 2023Ansbert GadickeDirector, 10% OwnerSale70.2K$1.88$131.9K
May 15, 2023Kevin C Tang10% OwnerPurchase44.9K$1.95$87.6K
May 10, 2023Kevin C Tang10% OwnerPurchase84.0K$1.95$163.8K
May 5, 2023Kevin C Tang10% OwnerPurchase289.6K$1.89$547.9K
Dec 14, 2022Alfonso Quintas CardamaChief Medical OfficerSale13.8K$1.10$15.1K
Dec 14, 2022Peter OlagunjuChief Technical OfficerSale4.8K$1.10$5.3K
Dec 14, 2022Angela JusticeChief People OfficerSale8.6K$1.10$9.4K
Dec 14, 2022Garry E MenzelPresident and CEOSale31.9K$1.10$35.0K
Dec 9, 2022Alfonso Quintas CardamaChief Medical OfficerSale7.9K$1.27$10.1K
Dec 9, 2022Garry E MenzelPresident and CEOSale18.4K$1.27$23.4K
Dec 9, 2022Angela JusticeChief People OfficerSale5.0K$1.27$6.3K
Dec 9, 2022Peter OlagunjuChief Technical OfficerSale2.8K$1.27$3.5K
Dec 8, 2022Alfonso Quintas CardamaChief Medical OfficerSale7.5K$1.35$10.1K
Dec 8, 2022Peter OlagunjuChief Technical OfficerSale2.6K$1.35$3.5K
Dec 8, 2022Garry E MenzelPresident and CEOSale23.4K$1.36$31.8K
Dec 8, 2022Angela JusticeChief People OfficerSale4.7K$1.35$6.3K
Dec 6, 2022Alfonso Quintas CardamaChief Medical OfficerSale3.6K$1.39$5.1K
Dec 6, 2022Peter OlagunjuChief Technical OfficerSale1.3K$1.39$1.8K
Dec 6, 2022Garry E MenzelPresident & CEOSale8.4K$1.39$11.7K
Dec 6, 2022Angela JusticeChief People OfficerSale2.3K$1.39$3.2K
Dec 16, 2020Mayur Ian SomaiyaChief Financial OfficerSale2.0K$35.00$70.0K
Nov 19, 2020Mayur Ian SomaiyaChief Financial OfficerSale3.7K$30.00$110.0K
Nov 13, 2020Robert HofmeisterChief Scientific OfficerSale20.0K$25.10$502.0K

Showing the 25 most recent of 39 Form 4 filings for TCR2 THERAPEUTICS INC..

Most active TCRR insiders

  • Morana Jovan-Embiricos6 filings
  • Alfonso Quintas Cardama4 filings
  • Angela Justice4 filings
  • Garry E Menzel4 filings
  • Kevin C Tang4 filings

Ask anything about TCRR insider activity

Use Trabud's AI agent to query TCR2 THERAPEUTICS INC.'s Form 4 history in plain English — "Show me TCRR CEO purchases this year" or compare it against any other ticker.

Open the AI agent

TCRR insider trading FAQ

Are TCR2 THERAPEUTICS INC. insiders buying or selling?

Across 39 SEC Form 4 filings, TCR2 THERAPEUTICS INC. (TCRR) insiders reported 10 open-market purchases totaling $65.7M and 29 sales totaling $16.8M. That is a net buying position of $48.9M.

How many insiders trade TCRR stock?

16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TCR2 THERAPEUTICS INC.. The most recent filing was accepted on May 31, 2023.

Where does Trabud get TCRR insider trading data?

All TCRR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content